We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

CMC Biologics Announces Development and Manufacturing Agreement with Harpoon Therapeutics

News   Dec 15, 2017

 
CMC Biologics Announces Development and Manufacturing Agreement with Harpoon Therapeutics
 
 
 

RELATED ARTICLES

UC San Diego Researchers Receive Funding to Pursue Novel Stem Cell-based Treatments

News

Two grants worth more than $2.2 million have been to University of California San Diego School of Medicine researchers investigating stem cell-based therapies for a rare genetic disorder that affects the heart and a chronic, progressive affliction of the lungs.

READ MORE

Neural Inflammation Critical for Stress-Induced Depression

News

Researchers have discovered that neural inflammation caused by our innate immune system plays an unexpectedly important role in stress-induced depression.

READ MORE

Enabling Technology in Cell-Based Therapies: Scale-Up, Scale-Out or Program In-Place

News

Technologies are reducing costs and changing the ways in which researchers and clinicians process and use therapeutic cells. Two new review articles detail the status of cell bioreactors in both stem cell and tissue/organ engineering applications.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE